Kura Oncology, Inc. SEC filings KURA
Kura Oncology, Inc. has 806 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Feb 29, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 13, 2024 | — |
| D | Filing | Feb 5, 2024 | — |
| CT ORDER | Filing | Feb 21, 2023 | — |
| EFFECT | Filing | Aug 18, 2020 | — |
| CORRESP | Letter to the SEC | Aug 14, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2020 | — |
| CT ORDER | Filing | Mar 17, 2020 | — |
| CT ORDER | Filing | Mar 17, 2020 | — |
| CT ORDER | Filing | Mar 17, 2020 | — |
| EFFECT | Filing | Aug 28, 2019 | — |
| CORRESP | Letter to the SEC | Aug 26, 2019 | — |
| CORRESP | Letter to the SEC | Aug 21, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2019 | — |
| EFFECT | Filing | Nov 21, 2018 | — |
| CORRESP | Letter to the SEC | Nov 19, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2018 | — |
| CT ORDER | Filing | Apr 26, 2018 | — |
| CT ORDER | Filing | Apr 26, 2018 | — |
| CT ORDER | Filing | Mar 22, 2018 | — |
| EFFECT | Filing | Dec 4, 2017 | — |
| CORRESP | Letter to the SEC | Nov 30, 2017 | — |
| CORRESP | Letter to the SEC | Nov 28, 2017 | — |
| CT ORDER | Filing | Sep 11, 2017 | — |
| CT ORDER | Filing | Mar 30, 2017 | — |
| EFFECT | Filing | Apr 14, 2016 | — |
| EFFECT | Filing | Apr 14, 2016 | — |
| CORRESP | Letter to the SEC | Apr 12, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2016 | — |
| CERTNAS | Auto-generated paper document | Nov 5, 2015 | — |
| POS EX | Filing | Nov 5, 2015 | — |
| EFFECT | Filing | Nov 4, 2015 | — |
| 8-A12B | Filing | Nov 4, 2015 | — |
| CORRESP | Letter to the SEC | Nov 2, 2015 | — |
| CORRESP | Letter to the SEC | Nov 2, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2015 | — |
| CT ORDER | Filing | Jul 27, 2015 | — |
| CT ORDER | Filing | Jul 27, 2015 | — |
| EFFECT | Filing | Jul 21, 2015 | — |
| CORRESP | Letter to the SEC | Jul 17, 2015 | — |
| CORRESP | Letter to the SEC | Jul 2, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2015 | — |
| CORRESP | Letter to the SEC | Jun 2, 2015 | — |
| UPLOAD | Letter from the SEC | May 18, 2015 | — |
| D | Filing | Mar 19, 2015 | — |
| SC 14F1 | Filing | Mar 6, 2015 | — |
| 10QSB | Filing | Aug 11, 2008 | Jun 30, 2008 |
| 10QSB | Filing | May 15, 2008 | Mar 31, 2008 |
| 10SB12G | Filing | Feb 1, 2008 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1422143
- Former names
- ZETA ACQUISITION CORP III (until Mar 10, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.